Oseltamivir Treatment for Influenza Linked to Fulminant Hepatitis, Liver Damage
An analysis of FDA Adverse Event Reporting System data suggests baloxavir marboxil has lower hepatic toxicity than oseltamivir and may be a safer option for patients with liver diseases.
Source: hcplive.com
